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Assessment of cortisol secretion in a huge sample of healthy children and adolescents requires not only a nonstressful and noninvasive protocol but also a practical approach to permit successful realization. The application of invasive techniques based on isotope dilution requires venipuncture and infusions of either stable or radioactively labeled cortisol in specialized hospitals or research units with subsequent sampling of blood and/or urine to recover labeled metabolites (19, 22, 50) . Additionally, administration of isotope-labeled tracers might influence endogenous cortisol production by negative feedback (18) . However, it has been shown that determination of urinary excretion rates of the major endogenous glucocorticoid metabolites presents a suitable alternative to isotopic methods for the determination of cortisol secretion (15, 19, 50) and gas chromatography-mass spectrometry (GC-MS) urinary steroid profiling has been successfully used in determining cortisol secretion in preterm infants (14) .
Meanwhile, measurement of urinary 24-h major cortisol metabolites is an established method used by numerous endocrine research groups (9, 16, 23, 29, 39, 41, 43, 49) to examine adrenocortical activity and/or glucocorticoid metabolism in healthy and ill children and adults. This relies on the fact that the sum of the seven major urinary cortisol metabolites (for details see SUBJECTS AND METHODS) encompasses almost 80% of the cortisol secreted per day by the adrenal gland (27, 40) . Although recent observations in children with congenital adrenal hyperplasia have suggested an increased cortisol clearance at puberty and have shown problems with glucocorticoid replacement therapy (6, 7), possible changes in cortisol secretion and cortisol metabolism in normal growing children have not been specifically investigated so far. In addition, it is unclear at what time the known sexual dimorphism with higher cortisol secretion rates in men than in women develops. This sexual dimorphism has been demonstrated in adults with stable-isotope tracer infusions (45) as well as with 24-h urinary cortisol metabolite excretion measurements (1, 30, 38) .
To examine the dynamics in cortisol secretion during growth and to test the hypothesis that the higher cortisol secretion in men than in women develops during puberty, we determined urinary glucocorticoid metabolite excretion rates noninvasively in a large sample of healthy children of the DONALD (Dortmund Nutritional and Anthropometric Longitudinally Designed) study (4, 34) .
SUBJECTS AND METHODS
Subjects and urine collections. The study group comprised 400 healthy children and adolescents (200 boys, 200 girls aged 3-18 yr) participating in the DONALD study (4, 34) . Data from these 400 children on urinary markers of adrenarche have already been published (32) . Fifty 24-h urine samples (25 from boys and 25 from girls) were randomly selected for each of the eight equally wide age groups. The study was approved by the Institutional Review Board of the Research Institute for Child Nutrition Dortmund, and parental consent and children's assent were obtained before entry into the study.
The participating children and their parents received instruction and written guidance to ensure compliance in the 24-h urine collection, which was performed at home by each subject (31, 34) .
Measurements, calculations, and background for adjustments. Anthropometric and dietary data were obtained as described in detail elsewhere (33, 34) . Urinary steroid profiles were determined using quantitative data produced by GC-MS analysis according to the method described previously (32, 37, 48) . In brief, after extraction of free and conjugated urinary steroids and enzymatic conjugate hydrolysis, GC-MS analysis was performed using the selected ion monitoring mode.
Daily urinary excretion rates were determined for cortisol (F), i.e., combined free and conjugated cortisol (F comb) and its major metabolites ( Fig. 1) , such as its tetrahydro-reduced metabolites 5␣-tetrahydrocortisol (a-THF; m/z 652), tetrahydrocortisol (THF; m/z 652), tetrahydrocortisone (THE; m/z 578), and its hexahydro-reduced metabolites ␣-cortol (m/z 523), ␤-cortol (m/z 523), ␣-cortolone (m/z 449), and ␤-cortolone (m/z 449). To assess overall cortisol secretion, these analyzed major urinary glucocorticoid metabolites were summed (40, 41, 43, 50) . Global activity of the enzymatic system of 11␤-hydroxysteroid dehydrogenase (11␤-HSD) was conventionally assessed by the ratio (a-THF ϩ THF)/THE. The net balance between 5␣-and 5␤-reductase was assessed by the ratio a-THF/THF (28, 37, 47) . Intra-assay precision (n ϭ 6) varied between 2.2% (for THF) and 3.6% (for THE) and interassay precision (n ϭ 6) between 1.1% (for ␣-cortol) and 2.3% (for a-THF).
For comparison, mean 24-h excretion data of the variables determined were provided (in tables and figure legends) also for healthy normal-weight adults aged ϳ30 yr. These data were taken from Tomlinson et al. (41) and Tsilchorozidou et al. (43) for men and women, respectively. The index for 5␣-reductase of men was obtained by division of the mean value for 5␣-THF (2,025 g/day) by the mean for THF (2,469 g/day) (41). Body surface area (BSA)-corrected excretions for adults were determined on the basis of average BSA values. For women an average BSA of 1.73 m 2 was assumed; for men an average BSA of 1.98 m 2 was calculated from height and weight means reported (41) .
Because there is a close functional-anatomic correlation between adrenal volume and BSA (21, 35) , glucocorticoid excretion rates were normalized to BSA. Accordingly, correction with BSA of 24-h urinary free cortisol, a marker that grossly integrates the plasma free (bioactive) cortisol concentration during the entire day (26) , has yielded relatively constant, age-independent values between ages 2 and 17 yr in healthy children (13) . Correction with urinary creatinine, however, yields the typical age-dependent decline in the cortisol/ creatinine ratio (13) , which is present for many urinary analytes, due to the fact that muscle mass and thus 24-h creatinine excretion show physiologically markedly steeper increases during growth than BSA and/or energy intake (24, 33, 34) . This age-related physiological variability is the reason why the ratio of glucocorticoid to creatinine (without further adjustments) is not a useful index for glucocorticoid status assessment, especially in children (3, 13) . Correcting urinary glucocorticoids by body mass index (BMI) would not yield useful ratios either, since this index of fatness shows a nadir around 5-6 yr (adiposity rebound), which would create cortisol/BMI variations with age that are not associated with growth processes, energy needs, or cortisol secretion.
Statistical analysis. Data are presented as means Ϯ SD and/or median and percentiles. Overall sex and age group effects were tested by two-way ANOVA. Subsequent analyses of the influence of age on hormonal and enzymatic variables during specific periods of Ϸ4 -6 yr duration were done (with age as a continuous predictor) using regression analysis. Sex differences in particular age groups were tested by unpaired t-test. P Ͻ 0.05 was considered statistically significant. All tests were two tailed. Calculations and analyses were performed using SAS for Windows (v. 8.2; Statistical Analysis System, Cary, NC).
RESULTS
Mean values Ϯ SD for BMI, BSA, daily energy intake, and urine volume of the subjects according to age and sex are shown in Table 1 . These data reflect normal developmental changes in the corresponding basic characteristics of healthy children and adolescents.
In Table 2 , 24-h urinary excretion rates of the three most important single glucocorticoid metabolites, THE, THF, and a-THF, are given according to age and sex. Table 3 shows the sums of total daily renal output (C21) of all seven major glucocorticoid metabolites (THF, a-THF, ␣-cortol, ␤-cortol, THE, ␣-cortolone, ␤-cortolone), reflecting overall cortisol secretion. Significant overall effects of age and sex were observed by two-way ANOVA for all individual glucocorticoid metabolites and the sums of metabolites presented in Tables 2  and 3 . Age and sex remained strong predictors for cortisol secretion (C21) even after urinary 24-h excretion rates of C21 were corrected for BSA (Table 4) . No significant sex difference is discernible for F comb excretion, whether corrected for BSA or not (Table 4) . Although the ratio F comb /BSA showed significant variation over the whole age range (3-18 yr), it was no longer significant for the age range from 3 to 15 yr (n ϭ 330, P ϭ 0.1; Table 4 ). Figure 2 shows a scatter plot of age-dependent 24-h excretion rates of the sum of the major urinary cortisol metabolites (C21) when normalized for BSA. In both sexes, cortisol secretion rate, reflected by the 24-h urinary excretion of C21, decreased significantly (P Ͻ 0.01) until the age of 8 yr. Thereafter, the cortisol secretion rate showed a clear increase for both sexes (P Ͻ 0.0001 in boys, P Ͻ 0.05 in girls). After the age of 11-12 yr, dissociation in cortisol secretion rates between the sexes could be noted: although cortisol secretion increased further in boys, it stagnated in girls. Sex differences for C21 adjusted for BSA were significant in age groups 15-16 yr (P Ͻ 0.05) and 17-18 yr (P Ͻ 0.01).
Furthermore, we investigated indexes for activities of the two primary enzyme systems involved in cortisol metabolism. Figure 3A depicts the age-dependent global activities of 11␤-HSD. The corresponding (a-THF ϩ THF)/THE ratios were not constant during childhood and showed a U-shaped course in both sexes. To assess age-dependent changes in the activity of the glucocorticoid-catabolic 5␣-reductase, we conventionally determined the a-THF/THF ratio, which in the first instance reflects the balance between 5␣-and 5␤-reductase. Increases in this ratio could therefore imply a decrease in 5␤-reductase or an increase in 5␣-reductase. However, since the 5␤-metabolites THF and THE do not decline in our children (relative to total cortisol secretion; compare Tables 2 and 3) , changes in the ratio a-THF/THF represent altered 5␣-reductase activity. Figure 3B shows that a dissociation emerges for 5␣-reductase between boys and girls after age 11-12 yr (sex difference: P Ͻ 0.05 in 15-to 16-yr-olds and P Ͻ 0.01 in 17-to 18-yr-olds).
DISCUSSION
In this paper, we have demonstrated that daily cortisol secretion, when corrected for BSA (C21/BSA), is by no means Data are presented as percentiles, median (P50), and means Ϯ SD. Each age group comprised 25 boys and 25 girls. C21, sum of all 7 major glucocorticoid metabolites: THF, ␣-THF, ␣-cortol, ␤-cortol, THE, ␣-cortolone, and ␤-cortolone.
a P Ͻ 0.0001 for age, P Ͻ 0.0001 for sex, and P Ͻ 0.0001 for sex ϫ age interaction (2-way ANOVA).
b Reported data for healthy adults aged ϳ30 yr; men: mean values Ϯ SE (41); women: median and (range) (43) .
constant throughout childhood and adolescence but shows a dynamic pattern, with a nadir around the age of 7-8 yr.
Thereafter, C21/BSA starts to rise again in boys and in girls, and after the age of 11-12 yr it becomes divergent between the sexes, with significantly higher levels in males. No such dynamics is discernible for urinary cortisol (F comb ) as conventionally measured by GC-MS. F comb /BSA was relatively constant over a wide age range in both sexes, especially during the period with the most dynamic changes in cortisol secretion, i.e., between age 3 and 15 yr. Since F comb is a combined parameter consisting only partly of urinary free cortisol, it is comprehensible that F comb /BSA is not necessarily totally age independent, as might be expected if this measure closely reflected integrated plasma free (bioactive) cortisol over 24 h. A considerable part of F comb consists of glucuronidated and sulfated cortisol, implying that changes in hepatic conjugation activity during growth may confound F comb / BSA as an accurate index for the noninvasive assessment of circulating bioactive free cortisol.
Our results corroborate the hypothesis that the reported higher cortisol secretion of men compared with women develops during puberty, a period during which the rough indicator of bioactive free cortisol in circulation F comb /BSA remains fairly constant. This strongly suggests that metabolic differences between males and females, which emerge during puberty, may be responsible. In accord with this, significant differences between the sexes were discernible for the index of 5␣-reductase activity that we assessed too (see below).
Measurement and summation of the major GC metabolites of 24-h urine samples (C21) allows a time-integrated, stressfree, in vivo examination of the overall amount of cortisol and cortisone originally secreted by the adrenal gland in large samples of healthy and/or ill subjects (9, 16, 23, 29, 39, 41, 43) . This is the reason that we could confirm, in healthy children and adolescents, stable-isotope infusion results (hitherto obtained mostly in small groups of normal and obese adults) that suggest that daily cortisol production rates vary considerably between individuals (10, 44, 45). Vierhapper et al. (45) , for example, found daily cortisol production rates ranging between 1,680 and 7,440 g⅐m Ϫ2 ⅐day Ϫ1 in 7 healthy women. This range corresponds closely with the variation range that we observed (Fig. 2) . In line with a commonly large interindividual variability are other results by stable-isotope dilution methodology, demonstrating that patients with proven Cushing's syndrome can have normal and patients without clinical and biochemical symptoms can have elevated cortisol productions (36) . The large interindividual variation in cortisol status parameters can be explained by genetic (8, 11, 20) and metabolic factors. Shifts in glucocorticoid metabolism are frequently responsible for marked changes in cortisol secretion in various illnesses. For example, elevated a-THF and normal THF excretion rates in patients with hyperthyroidism indicate an increased 5␣-reductase activity and thus a reduction in cortisol half-life (16) . This stimulated cortisol degradation explains why these patients frequently show an elevated cortisol secretion, necessary to maintain an appropriate bioactive free cortisol level in the circulation. A similar mechanism operates in patients with polycystic ovary syndrome (43) .
Earliest estimates of cortisol production rates in normal children and adolescents using isotope dilution with intrave- ). b P Ͻ 0.0001 for age, P ϭ 0.002 for sex, and P ϭ 0.01 for sex ϫ age interaction (2-way ANOVA). c P Ͻ 0.0001 for age, P ϭ 0.11 for sex, and P ϭ 0.4 for sex ϫ age interaction (2-way ANOVA).
d P Ͻ 0.0001 for age, P ϭ 0.45 for sex, and P ϭ 0.08 for sex ϫ age interaction (2-way ANOVA). e P ϭ 0.1 for age, P ϭ 0.11 for sex [regression analysis (with sex as dummy) for the age range 3-15 yr, n ϭ 330].
f Reported data for healthy adults aged ϳ30 yr; men: values are either mean Ϯ SE or calculated from the mean (division by BSA, see SUBJECTS AND METHODS) (41) ; women: calculated from the median by division by BSA, no Fcomb data available (43) . nous radiolabeled tracers yielded values around 12.1 Ϯ 2.9 mg⅐m Ϫ2 ⅐day Ϫ1 (mean Ϯ SD), which seemed to be constant over time. The number of subjects studied (n ϭ 20) was too low to permit reliable information about dynamic variations or sex differences regarding cortisol production (17) . Later, in a study employing high-performance liquid chromatographymass spectrometry and intravenous stable-isotope dilution, much lower cortisol production rates (mean Ϯ SD: 6.8 Ϯ
1.9⅐m
Ϫ2 ⅐day Ϫ1 ) were determined. In this (22) and further studies (5, 10) , cortisol production was not found to vary with sex or pubertal stage, probably because of the small numbers of children studied.
Significant sex differences in the production of cortisol could be demonstrated in a study investigating 24-h urinary steroid profiles by high-resolution GC (30) . The authors found higher total cortisol metabolites in men than in women (mg⅐m Ϫ2 ⅐day
Ϫ1
, mean Ϯ SD; men: 4.2 Ϯ 1.4; women: 2.9 Ϯ 1.0). These values were similar to those found in our adolescents 17-18 yr of age. Similar sex differences in urinary excretion rates of cortisol metabolites measured by GC were documented in another study in adults (38) and in a further investigation (45) using stable-isotope dilution with deuteriumlabeled cortisol and analysis by GC-MS (11.5 Ϯ 2.2 vs. 5.3 Ϯ 1.9 mg⅐m Ϫ2 ⅐day Ϫ1 in men and women, respectively). However, concerning the dynamic course of cortisol secretion throughout childhood and adolescence, our study is the first report on the point of time, i.e., the age of 11-12 yr, when this divergence in cortisol secretion begins. Earlier investigations on 24-h urinary steroid excretions in children (2, 15) did not report corresponding dynamic variations, probably due to inhomogeneous study population (hospitalized and nonhospitalized children; partly small numbers in certain age groups) and the fact that only selected glucocorticoid metabolites were evaluated.
Several studies in adults have tried to relate the observed sexual dimorphism to a change in 11␤-HSD-dependent cortisol metabolism (30, 42, 46) . However, the strictly parallel behavior of 11␤-HSD that we observed in both sexes does not allow any plausible explanation for the sexual dimorphism in cortisol secretion in adolescence. Therefore, our results do not support concepts explaining the sexual dimorphism in human cortisol metabolism on the basis of sex-specific regulation of 11␤-HSD. Our findings are consistent with previous observations of cortisol metabolite excretion in young adults (12) showing that differences in cortisol metabolite excretion between men and women could not be attributed to alterations in 11␤-HSD.
Concerning further cortisol metabolizing enzymatic systems, studies in adults have shown a predominance of 5␣-reduced cortisol metabolites over 5␤-reduced metabolites in males (12, 30, 42) . Our data showed (Fig. 2B ) that net activity of 5␣/5␤-reductases did not differ between boys and girls below the age of 11-12 yr. Thereafter, it became different between sexes with a higher ratio of 5␣-to 5␤-metabolites in males, thus confirming the above-mentioned observations in adults. Consecutively, our findings corroborate the hypothesis that sexual dimorphism in cortisol metabolite excretion is attributable to less 5␣-reductase activity in women, which means that cortisol is cleared less rapidly from plasma in women than in men (12) . The fact that we observed the start of divergence in net activity of 5␣-reductases around the beginning of puberty suggests an influence of gonadal steroids. In an earlier study, a higher increase in 5␣-metabolites of testosterone compared with 5␤-metabolites was observed after administration of human chorionic gonadotropin in humans (25) , indicating that androgens might increase 5␣-reductase activity. However, data on the regulation of 5␣/5␤-reductases by sex steroids are scarce, frequently inconsistent, and mostly originating from animal experiments (12) .
In summary, we have measured urinary markers of cortisol secretion and metabolism in children and adolescents by use of GC-MS. We found that overall cortisol secretion varies considerably with age and sex despite adjustment for BSA. Decreases of BSA-corrected C21 excretion rates in prepubertal children and diverging increases in adolescent males and females suggest that development-and sex-dependent changes in Fig. 3 . A: global activity of 11␤-HSD [urinary ratio (a-THF ϩ THF)/THE]; P Ͻ 0.0001 for age, P Ͻ 0.01 for sex, and P ϭ 0.93 for sex by age interaction (2-way ANOVA). Reported mean values for healthy adults aged ϳ30 yr: men, 0.98 (41); women, 0.84 (43) . B: activity of 5␣-reductase (urinary ratio a-THF/THF) according to age and sex (2-way ANOVA: P Ͻ 0.0001 for age, P Ͻ 0.01 for sex, and P Ͻ 0.05 for sex by age interaction). Reported mean values for healthy adults aged ϳ30 yr: men, 0.82 (41); women, 0.47 (43) . Total no. of 400 children applies for both A and B (boys F; girls E). Reported data for healthy adults aged ϳ30 yr: men, mean values Ϯ SE; women, median and (range).
cortisol secretion exist during normal childhood and adolescence. Our results corroborate the hypothesis that the sexual dimorphism of cortisol secretion reported for adults develops during puberty. Changes in steroid-metabolizing enzymes appear to be at least partly responsible. The findings point to a varying metabolic need for cortisol during growth and may bear importance for glucocorticoid replacement therapy.
